US 8,644,226

Application 12/162,589 · Granted Feb 4, 2014

Resource block candidate selection technique employing packet scheduling in wireless communication systems

Estimated expiration

January 18, 2030

3y 59d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTEP2007000648: Resource not found (404)
Earliest effective filing
Jan 25, 2007
+ 20 years
Jan 25, 2027
PTA +1089d
Jan 18, 2030
No TD
—
Final
Jan 18, 2030

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
November 17, 2008
Earliest effective filing
January 25, 2007
Issue date
February 4, 2014
PTA
+1089 days
Base expiry (before PTA)
January 25, 2027

January 25, 2007 + 20 years = January 25, 2027 + 1089 PTA days = January 18, 2030

  • National stage entry of application PCTEP2007000648, filed Jan 25, 2007

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 12/162,589 · US 8,644,226

PatentReply compiles the prosecution history behind US 8,644,226: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8644226

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.